The present study aims to evaluate the serum and saliva levels of sclerostin and DKK1, and to immunohistochemically evaluate the levels of Wnt1 and Wnt3a expression in the salivary gland, in patients with primary SS. This evidence concerns the gene WNT1 and synovial sarcoma.